Exogenous Volatile Organic Compound (EVOC(®)) Breath Testing Maximizes Classification Performance for Subjects with Cirrhosis and Reveals Signs of Portal Hypertension

Background: Cirrhosis detection in primary care relies on low-performing biomarkers. Consequently, up to 75% of subjects with cirrhosis receive their first diagnosis with decompensation when causal treatments are less effective at preserving liver function. We investigated an unprecedented approach...

Descripción completa

Detalles Bibliográficos
Autores principales: Ferrandino, Giuseppe, Ricciardi, Federico, Murgia, Antonio, Banda, Iris, Manhota, Menisha, Ahmed, Yusuf, Sweeney, Kelly, Nicholson-Scott, Louise, McConville, Lucinda, Gandelman, Olga, Allsworth, Max, Boyle, Billy, Smolinska, Agnieszka, Ginesta Frings, Carmen A., Contreras, Jorge, Asenjo-Lobos, Claudia, Barrientos, Viviana, Clavo, Nataly, Novoa, Angela, Riviotta, Amy, Jerez, Melissa, Méndez, Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669625/
https://www.ncbi.nlm.nih.gov/pubmed/38001958
http://dx.doi.org/10.3390/biomedicines11112957

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10669625/
https://www.ncbi.nlm.nih.gov/pubmed/38001958
http://dx.doi.org/10.3390/biomedicines11112957

Ejemplares similares